KalVista Pharmaceuticals
KALV
KALV
26 hedge funds and large institutions have $51.3M invested in KalVista Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $61.6M → $51.3M (-$10.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$447K | |
| 2 | +$178K | |
| 3 | +$108K | |
| 4 |
BlackRock
New York
|
+$88.6K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$45.4K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$385K | |
| 3 | -$146K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$111K |
| 5 |
Renaissance Technologies
New York
|
-$62.5K |